The latest edition of Medicines, Ethics and Practice (MEP) continues to evolve with many new, updated and revised sections.

The professional guide for pharmacists has been designed as an underpinning document to help pharmacists practise confidently and professionally. It embeds professionalism and professional judgement at the heart of the decision-making process.

The advice contained in MEP 41 intends to support day-to-day practice, rather than simply highlighting pharmacist’s statutory obligations. As such it will empower pharmacists, helping them to make the right decisions.

Look importantly, MEP has been designed and developed with our members for our members.

Topics covered by the MEP Topics covered by the MEP

  • Core concepts and skills
    • Patient or person centred healthcare
    • Medicines optimisation and pharmaceutical care
    • Professionalism and professional judgement
    • Clinical check
    • The pharmacist consultation in practice
    • Getting the culture right
    • Professional empowerment
    • Professional development
    • Research involvement
  • Underpinning knowledge – legislation and professional issues
    • Classification of medicines
    • Professional and legal issues: Pharmacy medicines
    • Professional and legal issues: Prescription- only medicines
    • Wholesale dealing
    • Additional legal and professional Issues
    • Veterinary medicines
    • Controlled Drugs
  • Londep resources
  • Professional standards
  • Londep code of conduct
  • Pharmacist Support
  • Appendices – General Pharmaceutical Council standards and guidance

MEP 41 MEP41

The following new sections have been added to this year’s edition:

  • Prescribing and dispensing to the same person 
  • New psychoactive substances

Significant revisions have also been made to the following sections based on member feedback, changes to legislation, standards, and policy developments etc:

  • Professionalism and professional judgement: Revised information on declaration of interests and signposting, changes to improve readability
  • Social media: References and quotations from GPhC standards of conduct, ethics and performance removed
  • Professional empowerment: Changes to clarify RPS resources and professional development programmes
  • Professional development: Updated introduction to professional development
  • Continuing Professional Development: Revised to reflect expected GPhC changes and support available from RPS
  • Research involvement: Full revision of text, new diagrams and mapping to GPhC standards for pharmacy professionals
  • Cough and cold medicines for children: Changes to bring text up-to-date
  • General prescription requirements: Revision to description of repeatable prescriptions and other minor changes to improve readability
  • Prescriptions from the EEA or Switzerland: Changes to improve readability
  • Administration: Revision to include a sub-section on covert administration and signposting
  • Emergency supply: Revised wording to improve clarity and readability
  • Dispensing valproate for girls and women: Revised to emphasise pharmacy actions
  • Summary of prescriber types and prescribing restrictions: updated to reflect practice situation in Scotland where the tariff does not enable reimbursement for unlicensed medicines prescribed by nurse independent prescribers
  • Wholesale dealing: Revision to improve clarity and improve readability
  • Delivery and posting of medicines to patients (including abroad): Revised to include information about the EU distance selling logo
  • Homeopathic and herbal remedies: Alignment of text to RPS policy on homeopathy
  • Collection and purchase of medicines by children: Changes to improve readability
  • Instalment direction for Schedule 2 and 3 Controlled Drugs: Update to remove context information which was relevant at the time of home office approved wording introduced
  • Destruction of Controlled Drugs: Updated with information about rinsings and removal of double negative
  • Record keeping and controlled drug registers: Updated to remove duplication and to improve readability
  • Disposing of spent methadone bottles: Updated to clarify
  • Londep resources: Revised with narrative to describe range of RPS resources available from RPS website and signposting.
  • Professional standards: Revised to include signposting to RPS process for developing standards, revised list of standards and additional descriptions for new standards
  • Working with partners, affiliates and other organisations: Revised as narrative description and signposting to RPS website.
  • Appendix 1 GPhC Standards for Pharmacy Professionals: Supersedes previous GPhC Standards of Conduct, Ethics and performance
  • Appendix 4 GPhC Guidance on patient confidentiality: revised by GPhC May 2017
  • Appendix 5 GPhC Guidance on consent: revised by GPhC May 2017
  • Appendix 6 GPhC Guidance on raising concerns: revised by GPhC May 2017
  • Appendix 7 GPhC Guidance on maintaining clear sexual boundaries: revised by GPhC May 2017
  • Appendix 8 GPhC Guidance on the provision of pharmacy services affected by religious and moral beliefs: Removed due to expected GPhC changes
  • Notes pages: Updated to include space for recording MEP learning notes to support future CPD, Faculty or Foundation entries

What's not covered by the MEP What's not covered by the MEP

Human A-Z list of medicines


Limited use in day-to-day practice as information is available by marketing authorisation on the packaging of the medicine.
Lists are not exhaustive and information exists elsewhere


RPS website: is currently being developed. A PDF copy of the A-Z list as it was in 2010 is available here.
BNF: CD schedule information and partial classification for medicines within formulary
Other: C&D price list, OTC directories, , Home Office list of Controlled Drugs

Lists derived from medicines legislation
wholesale lists
conditions under which smallpox vaccine can be administered


Reproduction of legislation and lists from legislation is not a core role of a professional body.
Some lists are of little relevance to daily practice
Alternative sources of information are available.


Dale and Appelbe’s Pharmacy and Medicines Law. 10th edition. 2013

CHIP or COSSH regulations


Comprehensive alternative source of information available


Comprehensive information available from the Health and Safety Executive.

Denatured alcohol


Comprehensive alternative source of information available


Dale and Appelbe’s Pharmacy and Medicines Law. 10th edition. 2013

Veterinary A-Z list of medicines


Reliable and robust alternative sources of information freely available


Community pharmacy contractual frramework


Comprehensive alternative source of information available


NHS Community Pharmacy Contractual Framework Service Development (England)

NHS Community Pharmacy Contractual Framework Service Development (Wales)

Specials/Unlicensed medicines


Comprehensive information available on RPS website and alternative sources


RPS:Professional guidance for the procurement and supply of Specials. December 2015.
RPS: Guidance for the prescribers of Specials. April 2016.
RPS: Advice/clarification on crushing tablets and opening capsules. June 2011. 
RPS: Information on pharmaceutical issues when crushing, opening or splitting oral dosage forms. June 2011
GPhC. Guidance for registered pharmacies preparing unlicensed medicines. See appendix 12 or 

Health and safety


Comprehensive alternative source of information available


Dale and Appelbe's Pharmacy and Medicines Law. 10th edition. 2013


Purchasing MEP

If you’re not eligible to be a member of the Society but are interested in purchasing a copy of MEP, you can do so by visiting the Pharmaceutical Press website.
Return To Top